Markets:

Overview

News

Currencies

International

Treasuries

aTyr Pharma, Inc. - Common Stock (NQ:ATYR)

0.8535 +0.0827 (+10.73%)

Streaming Delayed Price Updated: 12:37 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about aTyr Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Law Offices of Frank R. Cruz Encourages aTyr Pharma Inc. (ATYR) Shareholders To Inquire About Securities Fraud Class Action

October 17, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

Law Offices of Howard G. Smith Encourages aTyr Pharma Inc. (ATYR) Shareholders To Inquire About Securities Fraud Class Action

October 17, 2025

From Law Offices of Howard G. Smith

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATYR

October 17, 2025

From Pomerantz LLP

Via GlobeNewswire

Why Is aTyr Stock Falling Today? ↗

September 15, 2025

Via Stocktwits

Levi & Korsinsky Notifies Shareholders of aTyr Pharma, Inc. (ATYR) of a Class Action Lawsuit and an Upcoming Deadline

October 17, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Levi & Korsinsky Notifies Shareholders of aTyr Pharma, Inc. (ATYR) of a Class Action Lawsuit and an Upcoming Deadline

October 17, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Securities Fraud Investigation Into aTyr Pharma Inc. (ATYR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

October 16, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

October 16, 2025

From Law Offices of Howard G. Smith

Via Business Wire

Faruqi & Faruqi Reminds ATyr Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 9, 2025 - ATYR

October 16, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

Securities Fraud Investigation Into aTyr Pharma Inc. (ATYR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

October 15, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

aTyr Pharma, Inc.’s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman

October 15, 2025

From Hagens Berman

Via Business Wire

ATYR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against aTyr Pharma, Inc. and Encourages Investors to Contact the Firm

October 14, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

October 12, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR

October 12, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

ATYR Investor Notice: Robbins LLP Reminds Investors of the Securities Fraud Class Action Against aTyr Pharma, Inc.

October 10, 2025

From Robbins LLP

Via GlobeNewswire

aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ATYR

October 10, 2025

From DJS Law Group

Via Business Wire

ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm

October 10, 2025

From The Schall Law Firm

Via Business Wire

Rosen Law Firm Urges aTyr Pharma, Inc. (NASDAQ: ATYR) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

October 10, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

October 10, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of aTyr Pharma, Inc. - ATYR

September 24, 2025

From Pomerantz LLP

Via GlobeNewswire

Benzinga Bulls And Bears: Intel, FedEx, Cracker Barrel — And Markets Close At Record Highs ↗

September 20, 2025

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Via Benzinga

Top 3 Health Care Stocks That May Explode In September ↗

September 19, 2025

Via Benzinga

Goldman Sachs To Rally around 9%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

September 16, 2025

Via Benzinga

Crude Oil Rises 1%; Manufacturing Activity in New York Falls In September ↗

September 15, 2025

Via Benzinga

Which stocks are most active on Monday? ↗

September 15, 2025

Stay updated with the latest market activity on Monday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 15, 2025

Via Benzinga

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ATYR

September 15, 2025

From DJS Law Group

Via Business Wire

ATyr Pharma Stock Sinks, Plans FDA Review After Mixed Phase 3 Results ↗

September 15, 2025

ATyr Pharma's stock dips after Phase 3 trial of efzofitimod misses steroid reduction goal, but shows improvements in lung function and steroid withdrawal rates.

Via Benzinga

Nasdaq Gains Over 100 Points; Tesla Shares Spike Higher ↗

September 15, 2025

Via Benzinga

New Mountain Finance, Texas Instruments, Analog Devices And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 15, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.